The significance of increase in striatal D2 receptors in epileptic EL mice

被引:5
|
作者
Sutoo, D [1 ]
Akiyama, K [1 ]
机构
[1] Univ Tsukuba, Inst Med Sci, Tsukuba, Ibaraki 3058575, Japan
关键词
calcium/calmodulin-dependent protein kinase II; dopamine receptors; dopamine synthesis in brain; dopamine transporter; epileptic mice (EL mice); tyrosine hydroxylase; DEPENDENT PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; RAT-BRAIN; TYROSINE-HYDROXYLASE; NUCLEUS-ACCUMBENS; IMMUNOHISTOCHEMICAL LOCALIZATION; IMMUNOCYTOCHEMICAL LOCALIZATION; CATECHOLAMINE SYNTHESIS; MICROPHOTOMETRY SYSTEM; REGIONAL DISTRIBUTION;
D O I
10.1016/S0006-8993(03)02847-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study systematically and quantitatively analyzed the immunohistochemical distribution of various substances involved in synthesis, binding, and transport of dopamine in the forebrain of epileptic mice (EL mouse strain) using a brain mapping analyzer. A reduction in serum calcium levels decreases calcium /calmodulin-dependent-dopamine synthesis in the brain and subsequently increases susceptibility to epileptic convulsions and induces abnormal behavior in EL mice. The immunohistochemical levels of D-2 receptors in the medial area of the neostriatum were significantly higher in EL mice than in ddY mice (mother strain of EL mice), while there were no differences in the levels of tyrosine hydroxylase, calcium/calmodulin-dependent protein kinase II, calmodulin, D-1 receptors, and dopamine transporters. Together with our previous findings, the results suggest that the decrease in serum calcium levels and subsequent decrease in brain dopamine synthesis comprise the primary physiologic disorder in EL mice, and convulsions or increased D-2 receptors are secondarily-induced phenomena to improve or compensate for the principal disorder. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:24 / 30
页数:7
相关论文
共 50 条
  • [1] Modeling excess striatal D2 receptors in mice
    Kellendonk, Christoph
    GENETIC MODELS OF SCHIZOPHRENIA, 2009, 179 : 59 - 65
  • [2] Striatal dopamine D2 receptors and negative symptoms in mice
    Kellendonk, C.
    Simpson, E.
    Drew, M.
    Polan, J.
    Moore, H.
    Malapani, C.
    Balsam, P.
    Kandel, E.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 318 - 318
  • [3] ANXIOLYTIC PROPERTIES OF ALCOHOL ARE ENHANCED IN MICE WITH DECREASED STRIATAL DOPAMINE D2 RECEPTORS
    Bocarsly, M. E.
    Alvarez, V. A.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 45 : 60A - 60A
  • [4] Saturation of striatal D2 dopamine receptors by dozapine
    Nyberg, S
    Chou, YH
    Halldin, C
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2002, 5 (01): : 11 - 16
  • [5] Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET
    Honer, M
    Brühlmeier, M
    Missimer, J
    Schubiger, AP
    Ametamey, SM
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (03) : 464 - 470
  • [6] LATERALIZATION OF STRIATAL DOPAMINE (D2) RECEPTORS IN NORMAL RATS
    SCHNEIDER, LH
    MURPHY, RB
    COONS, EE
    NEUROSCIENCE LETTERS, 1982, 33 (03) : 281 - 284
  • [7] Dopamine Is Differentially Encoded by D2 Receptors in Striatal Subregions
    Engeln, Michel
    Fox, Megan E.
    Lobo, Mary Kay
    NEURON, 2018, 98 (03) : 459 - 461
  • [8] Abnormal motor function and the expression of striatal dopamine D2 receptors in manganese-treated mice
    Nam, Jungmin
    Kim, Kisok
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (10) : 1894 - 1897
  • [9] D1 receptor hypersensitivity in mice with low striatal D2 receptors facilitates select cocaine behaviors
    Lauren K. Dobbs
    Alanna R. Kaplan
    Roland Bock
    Khanhky Phamluong
    J. Hoon Shin
    Miriam E. Bocarsly
    Lindsay Eberhart
    Dorit Ron
    Veronica A. Alvarez
    Neuropsychopharmacology, 2019, 44 : 805 - 816
  • [10] D1 receptor hypersensitivity in mice with low striatal D2 receptors facilitates select cocaine behaviors
    Dobbs, Lauren K.
    Kaplan, Alanna R.
    Bock, Roland
    Phamluong, Khanhky
    Shin, J. Hoon
    Bocarsly, Miriam E.
    Eberhart, Lindsay
    Ron, Dorit
    Alvarez, Veronica A.
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (04) : 805 - 816